RECTAL ADENOCARCINOMA
Clinical trials for RECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink rectal tumors with fewer side effects
Disease control OngoingThis early-stage study tests the safety of combining the chemotherapy drug TAS-102 with standard radiation for people with stage II or III rectal cancer that hasn't spread. The goal is to find the best dose that kills tumor cells while limiting side effects, before surgery to rem…
Matched conditions: RECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 17, 2026 00:59 UTC
-
Smart radiation: MRI tailors treatment for rectal cancer
Disease control OngoingThis early-phase study tests whether using MRI scans during radiation therapy can help doctors adjust the treatment dose in real time for people with locally advanced rectal cancer. The goal is to improve the chance of a complete response, meaning no tumor remains after treatment…
Matched conditions: RECTAL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New drug combo shows promise against advanced rectal cancer
Disease control OngoingThis study tests whether adding the experimental drug LY2157299 to standard chemotherapy and radiation can improve outcomes for people with locally advanced rectal cancer. About 50 adults will receive the combination over 8 weeks, and researchers will track tumor response and imm…
Matched conditions: RECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
New combo shows promise for Hard-to-Treat colorectal cancer
Disease control OngoingThis study tests a combination of two drugs, cabozantinib and nivolumab, in people with advanced colorectal cancer that has not responded to standard treatments. The goal is to see if the combination can stop or shrink the cancer for at least 16 weeks. About 48 adults with a spec…
Matched conditions: RECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
Scientists hunt for genetic clues behind rising colorectal cancer in young adults
Knowledge-focused OngoingThis study explores genetic and lifestyle factors that may raise the risk of colorectal cancer in people under 50. Researchers will compare data from 818 patients and their family members to find genetic markers linked to early-onset disease. The goal is to better understand who …
Matched conditions: RECTAL ADENOCARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC